Genotyping - Global Market Outlook (2017-2023)

November 2017 | 168 pages | ID: GAA42401FFAEN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Genotyping market is estimated at $8.64 billion in 2016 and is expected to reach $31.19 billion by 2023 growing at a CAGR of 20.1% from 2016 to 2023. Growing awareness regarding personalized medicine and genetic diseases among the people, increase in target diseases occurrence and technological improvements in genotyping are the key factors driving the market growth. On the other hand, poor reimbursement policies are hampering the market growth. Demand for low cost genotyping service and huge flow of investments are the opportunities for the market to grow.

Genotyping is the procedure of deciding differences in the genetic make-up (genotype) of an individual by analyzing the individual's DNA sequence utilizing biological assays and comparing it to a reference sequence. It brings out the alleles an individual has inherited from their parents. The reagents and kits lead the market with the highest market share due to their wide usage and growing demand for genotyping tests. Personalized medicine holds the largest share and the growth can be attributed to increasing support of government for personalized medicine. North America is projected to be the leading markets in terms of market size, the growth is attributed to R&D investments and technological advancements. Asia Pacific is expected to witness high growth rate during the forecast period.

Some of the key players in the global genotyping market are GE Healthcare, Illumina, Inc, Agilent Technologies, Life Technologies Corporation (Thermofisher Scientific), Beckman Coulter, Roche, Qiagen NV, Affymetrix, Inc, Fluidigm Corp, Sequenom Inc, Douglas Scientific LLC, Premium Biosoft and Genewiz, Inc.

Technologies Covered:

• Sequencing
• Polymerase Chain Reaction (PCR)
• Capillary Electrophoresis
• Maldi-Tof
• Microarray
• Mass spectrometry
• Other Technologies

End-Users Covered:

• Diagnostic & Research Laboratories
• Pharmaceutical & Biopharmaceutical Companies
• Academic Institutions

Applications Covered:

• Pharmacogenomics
• Diagnostic Research
• Agricultural Biotechnology
• Animal Genetics
• Personalized medicine
• Drug discovery and development
• Other Applications

Product and Services Covered:

• Reagents & Kits
• Instruments
• Bioinformatics Software
• Genotyping Services

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• Italy
• France
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• South Korea
• Rest of Asia Pacific
• South America
• Argentina
• Brazil
• Chile
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• UAE
• Qatar
• South Africa
• Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Application Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL GENOTYPING MARKET, BY TECHNOLOGY

5.1 Introduction
5.2 Sequencing
  5.2.1 Sanger Sequencing
  5.2.2 Pyrosequencing
  5.2.3 Next Generation Sequencing (NGS)
5.3 Polymerase Chain Reaction (PCR)
  5.3.1 Digital PCR
  5.3.2 Real Time PCR
5.4 Capillary Electrophoresis
  5.4.1 Amplified Fragment Length Polymorphisms (AFLP)
  5.4.2 Single Strand Conformation Polymorphism (SSCP)
  5.4.3 Restriction Fragment Length Polymorphism (RFLP)
5.5 Maldi-Tof
5.6 Microarray
5.7 Mass spectrometry
5.8 Other Technologies

6 GLOBAL GENOTYPING MARKET, BY END-USER

6.1 Introduction
6.2 Diagnostic & Research Laboratories
6.3 Pharmaceutical & Biopharmaceutical Companies
6.4 Academic Institutions

7 GLOBAL GENOTYPING MARKET, BY APPLICATION

7.1 Introduction
7.2 Pharmacogenomics
7.3 Diagnostic Research
7.4 Agricultural Biotechnology
7.5 Animal Genetics
7.6 Personalized medicine
7.7 Drug discovery and development
7.8 Other Applications

8 GLOBAL GENOTYPING MARKET, BY PRODUCT AND SERVICES

8.1 Introduction
8.2 Reagents & Kits
8.3 Instruments
  8.3.1 Analyzers
  8.3.2 Sequencers & Amplifiers
8.4 Bioinformatics Software
8.5 Genotyping Services

9 GLOBAL GENOTYPING MARKET, BY GEOGRAPHY

9.1 Introduction
9.2 North America
  9.2.1 US
  9.2.2 Canada
  9.2.3 Mexico
9.3 Europe
  9.3.1 Germany
  9.3.2 UK
  9.3.3 Italy
  9.3.4 France
  9.3.5 Spain
  9.3.6 Rest of Europe
9.4 Asia Pacific
  9.4.1 Japan
  9.4.2 China
  9.4.3 India
  9.4.4 Australia
  9.4.5 New Zealand
  9.4.6 South Korea
  9.4.7 Rest of Asia Pacific
9.5 South America
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America
9.6 Middle East & Africa
  9.6.1 Saudi Arabia
  9.6.2 UAE
  9.6.3 Qatar
  9.6.4 South Africa
  9.6.5 Rest of Middle East & Africa

10 KEY DEVELOPMENTS

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 COMPANY PROFILING

11.1 GE Healthcare
11.2 Illumina, Inc
11.3 Agilent Technologies
11.4 Life Technologies Corporation (Thermofisher Scientific)
11.5 Beckman Coulter
11.6 Roche
11.7 Qiagen NV
11.8 Affymetrix, Inc
11.9 Fluidigm Corp
11.10 Sequenom Inc.
11.11 Douglas Scientific LLC
11.12 Premium Biosoft
11.13 Genewiz, Inc

List Of Tables

LIST OF TABLES

Table 1 Global Genotyping Market Outlook, By Region (2014-2023) (US $MN)
Table 2 Global Genotyping Market Outlook, By Technology (2014-2023) (US $MN)
Table 3 Global Genotyping Market Outlook, By Sequencing (2014-2023) (US $MN)
Table 4 Global Genotyping Market Outlook, By Sanger Sequencing (2014-2023) (US $MN)
Table 5 Global Genotyping Market Outlook, By Pyrosequencing (2014-2023) (US $MN)
Table 6 Global Genotyping Market Outlook, By Next Generation Sequencing (NGS) (2014-2023) (US $MN)
Table 7 Global Genotyping Market Outlook, By Polymerase Chain Reaction (PCR) (2014-2023) (US $MN)
Table 8 Global Genotyping Market Outlook, By Digital PCR (2014-2023) (US $MN)
Table 9 Global Genotyping Market Outlook, By Real Time PCR (2014-2023) (US $MN)
Table 10 Global Genotyping Market Outlook, By Capillary Electrophoresis (2014-2023) (US $MN)
Table 11 Global Genotyping Market Outlook, By Amplified Fragment Length Polymorphisms (AFLP (2014-2023) (US $MN)
Table 12 Global Genotyping Market Outlook, By Single Strand Conformation Polymorphism (SSCP) (2014-2023) (US $MN)
Table 13 Global Genotyping Market Outlook, By Restriction Fragment Length Polymorphism (RFLP) (2014-2023) (US $MN)
Table 14 Global Genotyping Market Outlook, By Maldi-Tof (2014-2023) (US $MN)
Table 15 Global Genotyping Market Outlook, By Microarray (2014-2023) (US $MN)
Table 16 Global Genotyping Market Outlook, By Mass spectrometry (2014-2023) (US $MN)
Table 17 Global Genotyping Market Outlook, By Other Technologies (2014-2023) (US $MN)
Table 18 Global Genotyping Market Outlook, By End User (2014-2023) (US $MN)
Table 19 Global Genotyping Market Outlook, By Diagnostic & Research Laboratories (2014-2023) (US $MN)
Table 20 Global Genotyping Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2014-2023) (US $MN)
Table 21 Global Genotyping Market Outlook, By Academic Institutions (2014-2023) (US $MN)
Table 22 Global Genotyping Market Outlook, By Application (2014-2023) (US $MN)
Table 23 Global Genotyping Market Outlook, By Pharmacogenomics (2014-2023) (US $MN)
Table 24 Global Genotyping Market Outlook, By Diagnostic Research (2014-2023) (US $MN)
Table 25 Global Genotyping Market Outlook, By Agricultural Biotechnology (2014-2023) (US $MN)
Table 26 Global Genotyping Market Outlook, By Animal Genetics (2014-2023) (US $MN)
Table 27 Global Genotyping Market Outlook, By Personalized medicine (2014-2023) (US $MN)
Table 28 Global Genotyping Market Outlook, By Drug discovery and development (2014-2023) (US $MN)
Table 29 Global Genotyping Market Outlook, By Other Applications (2014-2023) (US $MN)
Table 30 Global Genotyping Market Outlook, By Products & Services (2014-2023) (US $MN)
Table 31 Global Genotyping Market Outlook, By Reagents & Kits (2014-2023) (US $MN)
Table 32 Global Genotyping Market Outlook, ByInstruments (2014-2023) (US $MN)
Table 33 Global Genotyping Market Outlook, By Analyzers (2014-2023) (US $MN)
Table 34 Global Genotyping Market Outlook, By Sequencers & Amplifiers (2014-2023) (US $MN)
Table 35 Global Genotyping Market Outlook, By Bioinformatics Software (2014-2023) (US $MN)
Table 36 Global Genotyping Market Outlook, By Genotyping Services (2014-2023) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.